Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain

Paramita Mukherjee, Maris A. Cinelli, Soosung Kang, Richard B. Silverman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

82 Scopus citations

Abstract

Nitric oxide (NO) is an important signaling molecule in the human body, playing a crucial role in cell and neuronal communication, regulation of blood pressure, and in immune activation. However, overproduction of NO by the neuronal isoform of nitric oxide synthase (nNOS) is one of the fundamental causes underlying neurodegenerative disorders and neuropathic pain. Therefore, developing small molecules for selective inhibition of nNOS over related isoforms (eNOS and iNOS) is therapeutically desirable. The aims of this review focus on the regulation and dysregulation of NO signaling, the role of NO in neurodegeneration and pain, the structure and mechanism of nNOS, and the use of this information to design selective inhibitors of this enzyme. Structure-based drug design, the bioavailability and pharmacokinetics of these inhibitors, and extensive target validation through animal studies are addressed. This journal is

Original languageEnglish (US)
Pages (from-to)6814-6838
Number of pages25
JournalChemical Society Reviews
Volume43
Issue number19
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • Chemistry(all)

Fingerprint Dive into the research topics of 'Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain'. Together they form a unique fingerprint.

Cite this